73 related articles for article (PubMed ID: 8854780)
41. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
[TBL] [Abstract][Full Text] [Related]
42. [Evaluation of hepatic arterial infusion chemotherapy with levofolinate (l-LV) and 5-fluorouracil (5-FU) for multiple liver metastases from colorectal cancer].
Soma I; Kanai T; Fukuchi N; Izawa H; Yoshida T; Ebisui C; Sakita I; Fujimoto T
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2121-3. PubMed ID: 12484017
[TBL] [Abstract][Full Text] [Related]
43. [Weekly hepatic arterial infusion of high dose 5-fluorouracil for liver metastasis from colorectal cancer].
Takizawa K; Maruta M; Maeda K; Utsumi T; Masumori K; Matsumoto M; Koide Y; Aoyama H; Senda K; Ishihara O; Matsuoka H
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1718-20. PubMed ID: 10560379
[TBL] [Abstract][Full Text] [Related]
44. [Intra-arterial (5-FU/FA and FUDR) versus systemic chemotherapy (5-FU/FA) of non-resectable colorectal liver metastases].
Gassel HJ; Müller HH; Mattes P; Stieger R; Schramm H; Lorenz M
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1458-60. PubMed ID: 9931911
[TBL] [Abstract][Full Text] [Related]
45. [The 5-fluorouracil hepato-arterial infusion with oral UFT therapy for the hepatic and extra hepatic metastases of colorectal cancer].
Maruyama S; Maruyama M; Kato K; Koide A; Ohbu M; Hasegawa K; Takashima I; Ebuchi M
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1743-5. PubMed ID: 15553701
[TBL] [Abstract][Full Text] [Related]
46. High-dose infusional 5-fluorouracil combination therapy of metastatic gastric and colorectal cancer.
Loeffler TM; Hausamen TU
J Infus Chemother; 1996; 6(3):137-40. PubMed ID: 9229325
[TBL] [Abstract][Full Text] [Related]
47. [Pharmacokinetic studies on continuous intraportal 5-fluorouracil infusion].
Matsuzaki H; Yamamura T; Hanai A; Oikawa H; Kikuchi K; Seo K; Ozasa T; Akaishi O; Tsukikawa S; Yamaguchi S
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2121-3. PubMed ID: 7944418
[TBL] [Abstract][Full Text] [Related]
48. [Pharmacokinetic studies of continuous and bolus intraportal 5-fluorouracil infusion].
Hanai A; Yamamura T; Matsuzaki H; Oikawa H; Kikuchi K; Ozasa T; Akaishi O; Senda T; Katayama K
Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1536-9. PubMed ID: 1530302
[TBL] [Abstract][Full Text] [Related]
49. [Studies on 5-FU concentration and thymidine phosphorylase activity in tissues of patients with colorectal cancer after SF-SP administration].
Yamada K; Hase S; Yoshimura A; Haruyama K; Katsura Y; Sameshima T; Niwa K; Ishizawa T; Shimazu H
Gan To Kagaku Ryoho; 1990 Dec; 17(12):2333-7. PubMed ID: 2260869
[TBL] [Abstract][Full Text] [Related]
50. Establishment of an experimental model for continuous intraportal infusion of chemo/immunotherapeutic agents in the rat.
Rafique M; Adachi W; Shiohara E
Anticancer Res; 1995; 15(5B):1869-72. PubMed ID: 8572571
[TBL] [Abstract][Full Text] [Related]
51. [Suppression of postoperative liver metastases from colon cancer by continuous intraportal infusion of an angiogenesis inhibitor FR-118487].
Eda I; Soga H; Ueoka M; Yamashita K; Kawasaki S; Doihara H; Hirai R; Shimizu N
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1480-2. PubMed ID: 7574737
[TBL] [Abstract][Full Text] [Related]
52. [Portal blood levels of 5-FU administered intraperitoneally].
Kakizaki K; Teshima S; Yamauchi H
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1631-3. PubMed ID: 8373235
[TBL] [Abstract][Full Text] [Related]
53. Fu, Mansuripur, and Meystre reply.
Fu H; Mansuripur M; Meystre P
Phys Rev Lett; 1992 Mar; 68(9):1441. PubMed ID: 10046172
[No Abstract] [Full Text] [Related]
54. Wimmer, Fu, and Freeman respond.
Wimmer E; Fu CL; Freeman AJ
Phys Rev Lett; 1986 Sep; 57(12):1497. PubMed ID: 10033465
[No Abstract] [Full Text] [Related]
55. [The effect of intraportal chemotherapy in terms of administered dose of 5-FU].
Yamamura T; Matsuzaki H; Tsukikawa S; Akaishi O; Ozasa T; Miyake H; Tanaka K; Seo K; Oikawa H; Hanai A; Kikuchi K; Yamaguchi S
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1461-3. PubMed ID: 8854780
[TBL] [Abstract][Full Text] [Related]
56. [Final results of a randomized clinical trial of adjuvant intraportal chemotherapy for colorectal cancer: Intraportal Chemotherapy for Colorectal Cancer Group].
Yamamura T; Yabe K; Oka H; Kouzuma T; Kawahara H; Wakayama T; Sugiura A; Hagiwara M; Ohdate K; Miyajima N; Maeda C; Okamura R; Miyahara T; Moriyama Y; Yamaguchi S; Gunji A;
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1765-71. PubMed ID: 12402427
[TBL] [Abstract][Full Text] [Related]
57. [Is portal infusion chemotherapy uneffective for hepatic recurrence after resection for colorectal cancer?].
Yamamura T; Akaishi O; Tsukikawa S; Yamaguchi S; Yabe K
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1756-8. PubMed ID: 10560388
[TBL] [Abstract][Full Text] [Related]
58. [Continuous intraportal chemotherapy for prevention of metachronous hepatic metastasis in colorectal cancer].
Adachi W; Watanabe H; Yazawa K; Koide N; Koike S; Mihara M; Nakata S; Kajikawa S; Kuroda T; Amano J
Gan To Kagaku Ryoho; 1998 Apr; 25(5):697-703. PubMed ID: 9571967
[TBL] [Abstract][Full Text] [Related]
59. [Cooperative study of intraarterial preventive chemotherapy after resection of hepatic metastasis from colorectal cancer].
Tsuji Y; Hamada H; Kimura J; Katsuki Y; Kino S; Yamamoto Y; Ishizaki A; Kassai S; Suzuki K; Nakasaki H; Watanabe M; Tsujita K; Suzuki S; Itou Y; Kusano M
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1694-7. PubMed ID: 10560373
[TBL] [Abstract][Full Text] [Related]
60. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Kodaira S; Shatari T; Nozawa K
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
